YottaFireFDA Approves New Antibacterial Drug to Treat Skin InfectionsYottaFireThe Food and Drugs Administration approved the use of a new antibiotic, Dalvance, in the treatment of common bacterial skin infections acquired in hospitals. The intravenous antibiotic, Dalvance that is marketed by Chicago-based Durata Therapeutics, is to …FDA nod to Durata drug for acute skin infectionsDelhi Daily NewsNew Drug Dalvance Wins FDA Approval to Treat Skin InfectionsScience World ReportFDA Approves Durata Drug to Treat Acute Skin InfectionsNature World NewsABC Newsall 60 news articles …Read Full Story
FDA Approves New Antibacterial Drug to Treat Skin Infections - YottaFire
Real Estate of Cebu
